Publications en collaboration avec des chercheurs de University of South Florida (16)

2024

  1. Relevance of genetic testing in the gene-targeted trial era: the Rostock Parkinson’s disease study

    Brain, Vol. 147, Núm. 8, pp. 2652-2667

2021

  1. A Decade of Incorporating Social Sciences in the Integrated Marine Biosphere Research Project (IMBeR): Much Done, Much to Do?

    Frontiers in Marine Science, Vol. 8

  2. Growth and development of islet autoimmunity and type 1 diabetes in children genetically at risk

    Diabetologia, Vol. 64, Núm. 4, pp. 826-835

  3. Methyltransferase inhibitors restore SATB1 protective activity against cutaneous T cell lymphoma in mice

    Journal of Clinical Investigation, Vol. 131, Núm. 3

2019

  1. Severity dependent distribution of impairments in PSP and CBS: Interactive visualizations

    Parkinsonism and Related Disorders, Vol. 60, pp. 138-145

2018

  1. Effect of hydrolyzed infant formula vs conventional formula on risk of type 1 diabetes the TRIGR randomized clinical trial

    JAMA - Journal of the American Medical Association, Vol. 319, Núm. 1, pp. 38-48

2016

  1. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Autophagy, Vol. 12, Núm. 1, pp. 1-222

  3. Power calculations and placebo effect for future clinical trials in progressive supranuclear palsy

    Movement Disorders, Vol. 31, Núm. 5, pp. 742-747

2014

  1. A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy

    Movement Disorders, Vol. 29, Núm. 4, pp. 470-478

  2. Interleukin-1 antagonism in type 1 diabetes of recent onset: Two multicenter, randomized double-masked, placebo-controlled trials

    Diabetes Technology and Therapeutics

  3. Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease

    Nature Genetics, Vol. 46, Núm. 9, pp. 989-993

2013

  1. Interleukin-1 antagonism in type 1 diabetes of recent onset: Two multicentre, randomised, double-blind, placebo-controlled trials

    The Lancet, Vol. 381, Núm. 9881, pp. 1905-1915

  2. Solid-state NMR enhanced by dynamic nuclear polarization as a novel tool for ribosome structural biology

    Journal of Biomolecular NMR, Vol. 56, Núm. 2, pp. 85-93

2011

  1. Major and minor depression after traumatic brain injury

    Archives of Physical Medicine and Rehabilitation, Vol. 92, Núm. 8, pp. 1211-1219

2007

  1. The TRIGR trial: Testing the potential link between weaning diet and type 1 diabetes

    Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry, Vol. 7, Núm. 3, pp. 251-263